During the IPF Summit, APIE Therapeutics presented a poster describing the novel apelin receptor agonist (APT101) and its effects in models of acute and chronic lung injury
| Date/Time: | August 30, 2022 at 3:30 pm ET |
| Title: | Vascular Endothelium Repair and Regeneration as Target of Novel Small Molecule Anti-fibrotic and Anti-inflammatory Agent for the Treatment of Lung Fibrosis |
| Authors: | Willette RN1, Runyon S2, Maitra R2, Alegria E1 |
| 1) APIE-Therapeutics Inc. 2) Research Triangle Park |
